Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
dc.citation.doi | 10.1056/NEJMOA2113708 | |
dc.citation.epage | 1025 | |
dc.citation.spage | 1013 | |
dc.contributor.author | M OZELO | |
dc.contributor.author | Johnny Mahlangu | |
dc.contributor.author | K Pasi | |
dc.contributor.author | A Giermasz | |
dc.contributor.author | S leavitt | |
dc.contributor.author | E et al | |
dc.date.accessioned | 2023-10-10T11:53:51Z | |
dc.date.available | 2023-10-10T11:53:51Z | |
dc.identifier.citation | WOS | |
dc.identifier.issn | 0028-4793 | |
dc.identifier.uri | https://hdl.handle.net/10539/36671 | |
dc.journal.title | NEW ENGLAND JOURNAL OF MEDICINE | |
dc.journal.volume | 386 | |
dc.title | Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A |
Files
Original bundle
1 - 1 of 1